BSE Live
Prev. Close
Open Price
Bid Price (Qty.)
()
Offer Price (Qty.)
()
NSE Live
Mar 18, 14:15Prev. Close
48.00
Open Price
46.00
Bid Price (Qty.)
44.50 (1600)
Offer Price (Qty.)
48.50 (1600)
| Key Financial Ratios of Sunrest Lifescience (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 4.66 | 0.68 | 6.81 | 2.59 | 0.55 | |
| Diluted EPS (Rs.) | 4.66 | 0.68 | 6.81 | 2.59 | 0.55 | |
| Cash EPS (Rs.) | 4.87 | 0.75 | 7.24 | 837.00 | 208.50 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 37.72 | 33.06 | 10.38 | 1,072.00 | 294.90 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 37.72 | 33.06 | 10.38 | 1,072.00 | 294.90 | |
| Dividend / Share(Rs.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue from Operations/Share (Rs.) | 77.19 | 68.71 | 82.14 | 26,887.50 | 16,949.10 | |
| PBDIT/Share (Rs.) | 6.99 | 1.61 | 9.58 | 1,110.20 | 266.70 | |
| PBIT/Share (Rs.) | 6.78 | 1.38 | 9.15 | 1,050.30 | 223.70 | |
| PBT/Share (Rs.) | 6.08 | 1.38 | 9.15 | 1,050.30 | 223.70 | |
| Net Profit/Share (Rs.) | 4.66 | 0.53 | 6.81 | 777.10 | 165.50 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 9.05 | 2.34 | 11.66 | 4.12 | 1.57 | |
| PBIT Margin (%) | 8.78 | 2.01 | 11.13 | 3.90 | 1.31 | |
| PBT Margin (%) | 7.87 | 2.01 | 11.13 | 3.90 | 1.31 | |
| Net Profit Margin (%) | 6.03 | 0.76 | 8.29 | 2.89 | 0.97 | |
| Return on Networth / Equity (%) | 12.35 | 1.59 | 65.58 | 72.49 | 56.12 | |
| Return on Capital Employed (%) | 14.12 | 3.35 | 53.67 | 25.22 | 8.69 | |
| Return on Assets (%) | 5.68 | 0.89 | 12.22 | 5.96 | 1.74 | |
| Total Debt/Equity (X) | 0.38 | 0.43 | 0.69 | 3.02 | 7.85 | |
| Asset Turnover Ratio (%) | 1.10 | 1.41 | 1.66 | 2.39 | 0.00 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 1.94 | 3.31 | 1.41 | 1.42 | 1.35 | |
| Quick Ratio (X) | 1.48 | 2.63 | 1.07 | 1.16 | 1.13 | |
| Inventory Turnover Ratio (X) | 5.60 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 28.95 | 32.07 | 0.00 | 0.00 | 0.00 | |
| EV/Net Operating Revenue (X) | 0.87 | 1.09 | 0.00 | 0.00 | 0.00 | |
| EV/EBITDA (X) | 9.65 | 46.47 | 0.00 | 0.00 | 0.00 | |
| MarketCap/Net Operating Revenue (X) | 0.70 | 0.89 | 0.00 | 0.00 | 0.00 | |
| Retention Ratios (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Price/BV (X) | 1.43 | 1.85 | 0.00 | 0.00 | 0.00 | |
| Price/Net Operating Revenue | 0.70 | 0.89 | 0.00 | 0.00 | 0.00 | |
| Earnings Yield | 0.09 | 0.01 | 0.00 | 0.00 | 0.00 |